ARTICLE | Company News
Momenta, Teva, Novartis autoimmune news
September 13, 2010 7:00 AM UTC
The U.S. District Court for the Southern District of New York denied a motion for summary judgment filed by Novartis' Sandoz International GmbH generics unit and Momenta alleging that Teva's patents covering Copaxone glatiramer acetate are invalid due to indefiniteness. The court did not set a trial date. ...